Cancer-Med
Dear Investors, Here is your monthly update for August 2024 ✨ August 2024 started with extreme volatility in global markets, with fears of a hard landing in the US economy and the expectancy of bigger rate cuts. During the month, markets recovered most of the losses, leading to a powerfull rally in most stock indexes. During the Jackson Hole meeting, Jerome Powell made it clear that interest rate cuts are coming soon. Gold reached all-time highs, while Oil and cryptoassets fell. 💭 Find out more about what happened in August with eToro's Smart Portfolios Monthly summary here: etoro.turtl.co/story/etoros-investment-office-performance-report-aug24/ Performance Stats: Cancer-Med-> August: 3.12% , QTD: 11.10% YTD: 10.29% Benchmark (CNCRX - Range Oncology Therapeutics Index) -> August: -1.61% , QTD: 11.11% YTD: 11.79% Best Performer: $EXAS (Exact Sciences Corp) 35.05% Worst Performer: $GH (Guardant Health Inc) -27.18% Portfolio Indicated Dividend Yield: 0.92% ❓ Check out the portfolio fact sheet by clicking the following link: bullaware.com/factsheet/Cancer-Med This Smart Portfolio is a long-term investment vehicle. Therefore, since market trends can change over time, you should set realistic goals and assess your investment performance over a prolonged period. Please remember past performance is not indicative of any future performance.
Like CommentShare
null
.